The global cosmetic lasers market is booming, driven by the growing popularity of non-invasive and minimally invasive aesthetic procedures. This market, which reached US$ 1.3 Billion in 2022, is projected to reach US$ 3.8 Billion by 2031, growing at a CAGR of 13.3%. This growth is fueled by increasing demand, particularly among younger generations, who seek quick and effective solutions for their appearance.
A doctor advises checking the UV index on your phone daily to minimize the risk of skin cancer. He explains that even in the UK, where the UV index is often around 3, fair-skinned individuals should consider sunscreen daily. The higher the UV index, the greater the risk of skin damage, and individuals should take precautions like wearing protective clothing and seeking shade.
A female doctor in Andhra Pradesh, India, was violently assaulted by a patient while on duty. CCTV footage of the attack has gone viral, sparking outrage and renewed calls for increased safety measures for medical professionals. The incident comes amid a nationwide outcry for better doctor safety following a recent alleged murder of a doctor in Kolkata.
The global acute intermittent porphyria (AIP) market is projected to experience substantial growth, driven by advancements in AI, digital health technologies, and patient-centric drug development. AI-powered tools are enabling personalized treatment strategies and improved outcomes, while telemedicine and remote monitoring are revolutionizing AIP care delivery. This market analysis explores key trends, regional profiles, and prominent players shaping the future of AIP treatment.
A new strain of the mpox virus, clade Ib, is spreading rapidly in Africa and has been linked to cases in Europe and Asia. Scientists are concerned about the limited understanding of the virus, its severity, and transmission dynamics. The strain’s rapid evolution and potential for human-to-human transmission raise alarm bells, prompting calls for increased research and resources to combat the outbreak.
Oral cancer is a growing health concern globally, with India facing a particularly severe burden. This article explores the alarming statistics, causes, challenges, and potential solutions to combat this disease, emphasizing the critical need for awareness, early detection, and comprehensive care.
Cervical cancer is a preventable and treatable disease, but it remains a significant public health concern, particularly in low and middle-income countries. This article explores the causes, risk factors, prevention strategies, screening methods, and treatment options for cervical cancer, emphasizing the importance of early detection and regular screenings.
HOPE Therapeutics, a subsidiary of NRx Pharmaceuticals, is expanding its mental health treatment offerings by acquiring a network of interventional psychiatry clinics specializing in ketamine therapies. The acquisition, valued at $30 million, aims to create a unified patient-centered approach combining pharmaceutical therapies and FDA-approved technologies.
Labcorp is working with US health regulators to potentially increase its mpox testing capabilities in response to a new viral strain detected outside of Africa. The company currently processes around 500 tests monthly but can ramp up to 25,000 if necessary. This comes as global health authorities are concerned about the spread of the clade Ib variant, previously found in Central Africa, which has been identified in countries like Sweden and Thailand.
SI-BONE, Inc. (SIBN) has received FDA 510(k) clearance for its iFuse TORQ TNT implant system, designed for the specific anatomical needs of pelvic fragility fractures. This innovative system promises to be more effective than current treatments like cannulated screws, offering early fixation, reduced screw backout, and faster patient recovery. The news highlights SI-BONE’s commitment to developing solutions for unmet clinical needs in the growing sacroiliac joint fusion market.
